J Wozniak1, S V Faraone, E Mick, M Monuteaux, A Coville, J Biederman. 1. Clinical and Research Program in Pediatric Psychopharmacology and Adult ADHD at Massachusetts General Hospital, Boston, MA 02114, USA. jwozniak@partners.org
Abstract
BACKGROUND: To estimate the spectrum of familial risk for psychopathology in first-degree relatives of children withunabridged DSM-IV bipolar-I disorder (BP-I). METHOD: We conducted a blinded, controlled family study using structured diagnostic interviews of 157 children with BP-I probands (n=487 first-degree relatives), 162 attention deficit hyperactivity disorder (ADHD) (without BP-I) probands (n=511 first-degree relatives), and 136 healthy control (without ADHD or BP-I) probands (n=411 first-degree relatives). RESULTS: The morbid risk (MR) of BP-I disorder in relatives of BP-I probands (MR=0.18) was increased 4-fold [95% confidence interval (CI) 2.3-6.9, p<0.001] over the risk to relatives of control probands (MR=0.05) and 3.5-fold (95% CI 2.1-5.8, p<0.001) over the risk to relatives of ADHD probands (MR=0.06). In addition, relatives of children withBP-I disorder had high rates of psychosis, major depression, multiple anxiety disorders, substance use disorders, ADHD and antisocial disorders compared with relatives of control probands. Only the effect for antisocial disorders lost significance after accounted for by the corresponding diagnosis in the proband. Familial rates of ADHD did not differ between ADHD and BP-I probands. CONCLUSIONS: Our results document an increased familial risk for BP-I disorder in relatives of pediatric probands with DSM-IV BP-I. Relatives of probands with BP-I were also at increased risk for other psychiatric disorders frequently associated with pediatric BP-I. These results support the validity of the diagnosis of BP-I in children as defined by DSM-IV. More work is needed to better understand the nature of the association between these disorders in probands and relatives.
RCT Entities:
BACKGROUND: To estimate the spectrum of familial risk for psychopathology in first-degree relatives of children with unabridged DSM-IV bipolar-I disorder (BP-I). METHOD: We conducted a blinded, controlled family study using structured diagnostic interviews of 157 children with BP-I probands (n=487 first-degree relatives), 162 attention deficit hyperactivity disorder (ADHD) (without BP-I) probands (n=511 first-degree relatives), and 136 healthy control (without ADHD or BP-I) probands (n=411 first-degree relatives). RESULTS: The morbid risk (MR) of BP-I disorder in relatives of BP-I probands (MR=0.18) was increased 4-fold [95% confidence interval (CI) 2.3-6.9, p<0.001] over the risk to relatives of control probands (MR=0.05) and 3.5-fold (95% CI 2.1-5.8, p<0.001) over the risk to relatives of ADHD probands (MR=0.06). In addition, relatives of children with BP-I disorder had high rates of psychosis, major depression, multiple anxiety disorders, substance use disorders, ADHD and antisocial disorders compared with relatives of control probands. Only the effect for antisocial disorders lost significance after accounted for by the corresponding diagnosis in the proband. Familial rates of ADHD did not differ between ADHD and BP-I probands. CONCLUSIONS: Our results document an increased familial risk for BP-I disorder in relatives of pediatric probands with DSM-IV BP-I. Relatives of probands with BP-I were also at increased risk for other psychiatric disorders frequently associated with pediatric BP-I. These results support the validity of the diagnosis of BP-I in children as defined by DSM-IV. More work is needed to better understand the nature of the association between these disorders in probands and relatives.
Authors: B Geller; B Zimerman; M Williams; K Bolhofner; J L Craney; M P Delbello; C A Soutullo Journal: J Child Adolesc Psychopharmacol Date: 2000 Impact factor: 2.576
Authors: B Geller; K Bolhofner; J L Craney; M Williams; M P DelBello; K Gundersen Journal: J Am Acad Child Adolesc Psychiatry Date: 2000-12 Impact factor: 8.829
Authors: Joseph Biederman; Sarah W Ball; Michael C Monuteaux; Eric Mick; Thomas J Spencer; Michelle McCREARY; Michelle Cote; Stephen V Faraone Journal: J Am Acad Child Adolesc Psychiatry Date: 2008-04 Impact factor: 8.829
Authors: K R Merikangas; L Cui; L Heaton; E Nakamura; C Roca; J Ding; H Qin; W Guo; Y Y Shugart; Y Yao-Shugart; C Zarate; J Angst Journal: Mol Psychiatry Date: 2013-10-15 Impact factor: 15.992
Authors: Joseph Biederman; Stephen V Faraone; Carter Petty; Marykate Martelon; K Yvonne Woodworth; Janet Wozniak Journal: J Psychiatr Res Date: 2012-09-11 Impact factor: 4.791
Authors: Joseph Biederman; Marykate Martelon; Stephen V Faraone; K Yvonne Woodworth; Thomas J Spencer; Janet R Wozniak Journal: J Affect Disord Date: 2012-11-17 Impact factor: 4.839
Authors: Joseph Biederman; Janet Wozniak; Mary Kate Martelon; Thomas J Spencer; Yvonne Woodworth; Gagan Joshi; Andrea Spencer; Mai Uchida; Amelia Kotte; Stephen V Faraone Journal: Psychiatry Res Date: 2013-06-20 Impact factor: 3.222
Authors: Thomas J Spencer; Stephen V Faraone; Craig B H Surman; Carter Petty; Allison Clarke; Holly Batchelder; Janet Wozniak; Joseph Biederman Journal: Postgrad Med Date: 2011-09 Impact factor: 3.840
Authors: Janet Wozniak; Joseph Biederman; Mary Kate Martelon; Mariely Hernandez; K Yvonne Woodworth; Stephen V Faraone Journal: J Affect Disord Date: 2013-02-26 Impact factor: 4.839